Rodrigo Perez Pereira
Universidade Federal do Rio Grande do Sul · 36 works · 865 citations · h-index 5
Top works
- Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial
- Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study
- Factors associated with uncontrolled asthma in Porto Alegre, Brazil
- Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAFV600 mutation–positive melanoma
- Superoxide Dismutase Activity in Adriamycin-Induced Cardiotoxicity in Humans: A Potential Novel Tool for Risk Stratification
- 1102P Clinical benefit in BRAFV600 mutation-positive melanoma defined by programmed death ligand 1 (PD-L1) and/or lactate dehydrogenase (LDH) status: Exploratory analyses from the IMspire150 study
- A Phase II Trial of Perioperative Oral Itraconazole for the Management of Low‐Risk Basal Cell Carcinoma
- Overall survival (OS) with first-line atezolizumab (A) or placebo (P) in combination with vemurafenib (V) and cobimetinib (C) in BRAFV600 mutation-positive advanced melanoma: Second interim OS analysis of the phase 3 IMspire150 study.
- Superoxide dismutase activity in doxorubicin-induced cardiotoxicity in humans: A novel tool for risk stratification
- Patient-reported outcomes (PROs) from the phase III IMspire150 trial of atezolizumab (A) + cobimetinib (C) + vemurafenib (V) in patients (pts) with BRAFV600+melanoma.
- Neoadjuvant itraconazole (I) in patients (pts) with resectable basal cell carcinoma (BCC): A phase II multistage study.
- Pharmacoeconomic Analysis of Neoadjuvant Immunotherapy for Stage III Melanoma in Brazilian Private Healthcare: Evidence from NADINA Trial
- Comparação entre métodos de avaliação da função ventricular em pacientes submetidos à quimioterapia com adriamicina
- Comparação de métodos de avaliação da função ventricular no seguimento de pacientes submetidos à quimioterapia com adriamicina
- Rethinking rectal cancer management through COVID: Real word evidence in a public hospital in the south of Brazil.
- Economic Evaluation of Ipilimumab/Nivolumab versus Relatlimab/Nivolumab Immunotherapy Regimens: A Pharmacoeconomic Analysis in the Brazilian Context
- Neoadjuvant Short-Course Radiotherapy Followed by Chemotherapy for Rectal Adenocarcinoma: Analysis of Clinical and Pathological Responses of Patients Treated in a Brazilian Tertiary General Hospital
- The Current Successes (and Failures) in the Treatment of Cutaneous Metastatic Melanoma
- Treatment patterns and real-world outcomes with immunotherapies in the first line setting of metastatic melanoma
- Outcomes after the diagnosis of brain metastases in Brazilian NSCLC patients.